These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 34011981

  • 21. Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Role of Endothelin-1 in the Vascular Tone Dysregulation.
    Cambras T, Zerón-Rugerio MF, Díez-Noguera A, Zaragozá MC, Domingo JC, Sanmartin-Sentañes R, Alegre-Martin J, Castro-Marrero J.
    Int J Mol Sci; 2023 Mar 02; 24(5):. PubMed ID: 36902264
    [Abstract] [Full Text] [Related]

  • 22. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M, Twisk FN, Kubera M, Ringel K.
    J Affect Disord; 2012 Feb 02; 136(3):933-9. PubMed ID: 21975140
    [Abstract] [Full Text] [Related]

  • 23. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Med Sci Monit; 2011 Apr 02; 17(4):SC11-5. PubMed ID: 21455120
    [Abstract] [Full Text] [Related]

  • 24. Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review.
    Tsamou M, Kremers FAC, Samaritakis KA, Roggen EL.
    Int J Mol Sci; 2024 Sep 03; 25(17):. PubMed ID: 39273498
    [Abstract] [Full Text] [Related]

  • 25. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S.
    Mol Med; 2018 Aug 14; 24(1):44. PubMed ID: 30134818
    [Abstract] [Full Text] [Related]

  • 26. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Fenouillet E, Vigouroux A, Steinberg JG, Chagvardieff A, Retornaz F, Guieu R, Jammes Y.
    J Transl Med; 2016 Aug 31; 14(1):251. PubMed ID: 27580693
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scherbakov N, Szklarski M, Hartwig J, Sotzny F, Lorenz S, Meyer A, Grabowski P, Doehner W, Scheibenbogen C.
    ESC Heart Fail; 2020 Jun 31; 7(3):1064-1071. PubMed ID: 32154656
    [Abstract] [Full Text] [Related]

  • 29. Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.
    Xu J, Lodge T, Kingdon C, Strong JWL, Maclennan J, Lacerda E, Kujawski S, Zalewski P, Huang WE, Morten KJ.
    Adv Sci (Weinh); 2023 Oct 31; 10(30):e2302146. PubMed ID: 37653608
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.
    J Affect Disord; 2013 Sep 05; 150(2):223-30. PubMed ID: 23664637
    [Abstract] [Full Text] [Related]

  • 32. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Cheng Y, Xu SM, Takenaka K, Lindner G, Curry-Hyde A, Janitz M.
    Gene; 2023 Aug 15; 877():147568. PubMed ID: 37328077
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, Robertson CE, Schrodi SJ, Yale S, Frank DN.
    PLoS One; 2015 Aug 15; 10(12):e0145453. PubMed ID: 26683192
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology.
    Nepotchatykh E, Elremaly W, Caraus I, Godbout C, Leveau C, Chalder L, Beaudin C, Kanamaru E, Kosovskaia R, Lauzon S, Maillet Y, Franco A, Lascau-Coman V, Bouhanik S, Gaitan YP, Li D, Moreau A.
    Sci Rep; 2020 Nov 12; 10(1):19620. PubMed ID: 33184353
    [Abstract] [Full Text] [Related]

  • 38. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, Hanson MR.
    J Clin Invest; 2020 Mar 02; 130(3):1491-1505. PubMed ID: 31830003
    [Abstract] [Full Text] [Related]

  • 39. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, de Kretser DM.
    J Transl Med; 2017 Mar 16; 15(1):60. PubMed ID: 28302133
    [Abstract] [Full Text] [Related]

  • 40. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R, Kashi A, Nemat-Gorgani M, Wilhelmy J, Davis RW.
    Proc Natl Acad Sci U S A; 2019 May 21; 116(21):10250-10257. PubMed ID: 31036648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.